PLAY PODCASTS
Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Audio Recap
Episode 97

Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Audio Recap

Listen to expert insights from Renslow Sherer, MD, on updates and new COVID-19 data from IDWeek 2021, including prevention, treatment for outpatients and hospitalized patients, and long-term outcomes.

Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD

October 29, 202155m 38s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Renslow Sherer, MD, discusses new COVID-19 data from IDWeek 2021, including:

  • Prevention of COVID-19
    • ChAdOx1 nCoV-19
    • Ad26.COV2.S
    • Tixagevimab plus cilgavimab
  • Outpatients with COVID-19
    • Remdesivir IV
    • Molnupiravir
  • Hospitalized patients with COVID-19
    • Baricitinib
    • Lenzilumab
    • Casirivimab plus imdevimab
  • Long-term COVID-19 outcomes
    • Sustained recovery

Presenter:

Renslow Sherer, MD
Director
International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Link to full program and downloadable slides:
https://bit.ly/3BCHF2E


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

remdesivircas + imdevpreventionoutpatient remdesivirchadox1 ncov-19inpatient treatmentasymptomatic covid-19molnupiravirlive-airvaccinesviral clearanceoutpatient treatmentsingle dosesymptomatic covid-19lenzilumabcov-barriermonoclonal antibodies for treatmentazd1222delta variantcovid-19tixagevimab + cilgavimabsustained recoveryj&jcasirivimab + imdevimabbeta variantidweekmove-inproventazd7442variants of concernmonoclonal antibodiesvaccinationbaricitinibmove-outad26.cov2.smabmab for prevention